Description
Marijuana products have greater potency and higher levels of tetrahydrocannabinol (THC) than ever before. THC levels in marijuana products are regularly exceeding 20%, but this is mild in comparison to various and popular types of cannabis concentrates collectively known as “dabs".
According to studies compiled by the National Institutes of Health, high concentrations of THC can increase a person's risk of experiencing psychosis.
As a result, mental health specialists are faced with a clinical dilemma - how to clearly identify a substance-induced psychosis from a primary psychotic illness or a psychotic illness with comorbid substance use. This could possibly be a subtle conundrum and a chance for elucubration, yet it becomes vastly more important when treating and choosing the best therapeutic strategy for patients.
So, for this course, Dr. Jeremy Sharp sits down with Craig Heacock to take a deep dive into substance-induced psychosis. Here are a few discussion points that come up:
- What exactly is substance-induced psychosis?
- Is it qualitatively different than “regular” psychosis?
- What are the risk factors for developing substance-induced psychosis?
- What is the prognosis after a substance-induced psychotic break?
Target audience: Psychologists, mental health counselors, marriage and family therapists, social workers, addiction counselors, nurses.
Content Category: Testing/Assessment/Clinical; Clinical Assessment; Treatment Plan; Discharge and Continuing Care
This CE course is designated as intermediate.
This interview was published in November of 2022.
Conflict of interest or commercial support disclaimer: There are no conflicts of interest to report
Asynchronous, distance learning. Non-interactive. Recorded audio with transcript.
Author Bio
ABOUT DR. CRAIG HEACOCK
Dr. Craig Heacock is an adolescent, adult, and addiction psychiatrist in Fort Collins, Colorado where he also hosts and co-produces a psychiatric storytelling podcast called Back from the Abyss. He has a special interest in the use of ketamine and psychedelics to treat mood disorders and PTSD. He is a graduate of the University of New Mexico School of Medicine and did his psychiatry training at Brown University.
ABOUT DR. JEREMY SHARP
Dr. Jeremy Sharp is a licensed psychologist and Clinical Director at the Colorado Center for Assessment & Counseling, a private practice founded in 2009 that has grown to over 20 clinicians. He earned an undergraduate degree in Experimental Psychology from the University of South Carolina before getting a Master’s and PhD in Counseling Psychology from Colorado State University. He specializes in psychological and neuropsychological evaluation with kids and adolescents.
As the host of the Testing Psychologist Podcast, Dr. Sharp provides private practice consulting for psychologists and other mental health professionals who want to start or grow psychological testing services in their practices. He lives in Fort Collins, Colorado with his wife (also a therapist) and two young kids.
CE Approvals
At Health, LLC is approved by the American Psychological Association to sponsor continuing education for psychologists. At Health, LLC maintains responsibility for this program and its content.
At Health, LLC has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6949. Programs that do not qualify for NBCC credit are clearly identified. At Health, LLC is solely responsible for all aspects of the programs.
Athealth.com is approved as a continuing education provider by the National Association of Alcoholism and Drug Abuse Counselors (NAADAC) Provider #148460.
At Health, LLC, Provider #1707, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. At Health, LLC, maintains responsibility for this course. ACE provider approval period: 5/3/2023-5/3/2026.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for social work in Arkansas. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for social workers, professional counselors, marriage and family therapists, master's level psychologists, licensed clinical psychotherapists, and alcohol and other drug abuse counselors in Kansas. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for mental health practice and for social work in Nebraska. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for psychologists, pastoral psychotherapists, clinical social workers, clinical mental health counselors, marriage and family therapists, and alcohol and drug abuse counselors in New Hampshire. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for social workers, professional counselors, marital and family therapists, and clinical pastoral therapists in Tennessee. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
Other jurisdictions may accept trainings offered by At Health, LLC for your continuing education requirements. Restrictions may apply. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.”
.
Page last modified or reviewed by athealth.com on Nov 1, 2024.
Learning Objectives
Based on the content of this course, I can:
- Explain what substance-induced psychosis is
- Describe the differences between psychosis and substance-induced psychosis
- List some of the risk factors for developing substance-induced psychosis
- Discuss the prognosis after a substance-induced psychotic break
Terald (verified owner) –
Jerine (verified owner) –
Emily (verified owner) –
Vanessa (verified owner) –
kathleen (verified owner) –
Christopher (verified owner) –
Kendra (verified owner) –